The antibacterial activity of the new penem compound HRE 664 was evaluated in 451 clinical isolates, including ampiciflin-resistant members of the family Enterobacteriaceae, Acinetobacter spp., Haemophilus influenzae, Staphylococcus aureus, and beta-hemolytic streptococci, and compared with those of piperacillin, ceftazidime, ceftriaxone, aztreonam, imipenem, and the penem compound Sch 34343. The new agent HRE 664 exhibited antibacterial activity comparable to that of the penem Sch 34343 and imipenem. The MICs of the new agent HRE 664 for 90% of the strains tested ranged from 1 to 4 ,ug/ml against Enterobacteriaceae and were 0.06
The antibacterial activity of the new penem compound HRE 664 was evaluated in 451 clinical isolates, including ampiciflin-resistant members of the family Enterobacteriaceae, Acinetobacter spp., Haemophilus influenzae, Staphylococcus aureus, and beta-hemolytic streptococci, and compared with those of piperacillin, ceftazidime, ceftriaxone, aztreonam, imipenem, and the penem compound Sch 34343. The new agent HRE 664 exhibited antibacterial activity comparable to that of the penem Sch 34343 and imipenem. The MICs of the new agent HRE 664 for 90% of the strains tested ranged from 1 to 4 ,ug/ml against Enterobacteriaceae and were 0.06 ,ug/ml for Staphylococcus aureus and 0.125 ,ug/ml for beta-hemolytic streptococci.
Within recent years beta-lactam derivatives with altered ring structures such as the penems have been synthesized (1, 3) . Such compounds exhibit good antibacterial activity against gram-positive and gram-negative species, on the one hand, and stability to a variety of beta-lactamases, on the other (6, 8, 10, 11) . However, with the exception of the penem compound CGP 31608 (CIBA-GEIGY Corp., Summit, N.J.), they are not active against Pseudomonas aeruginosa (6, 7, 9, 11) . In this study the antibacterial effect of a new penem compound (HRE 664) was evaluated against clinical isolates; and the results were compared with those obtained with broad-spectrum penicillins, cephalosporins, and structurally related agents (Fig. 1) .
All 451 strains used in this study were isolated from clinical specimens in our routine laboratory within the last 4 years. All members of the family Enterobacteriaceae included in this study exhibited resistance to ampicillin (MIC, >8 ,ug/ml). Fermenting gram-negative rods were identified with'the API 20E system (Analytab Products, Bio-Mdrieux, Nurtingen, Federal Republic of Germany); all other bacteria were identified by well-known standard procedures (2, 4) . MICs were determined in Mueller-Hinton broth with twofold serial dilutions that yielded a final inoculum of 5 x 105 CFU/ ml. An incubation temperature of 370C was maintained, with the single exception of Staphylococcus aureus, which was incubated at 32°C to detect oxacillin resistance (5) . Susceptibility testing of Haemophilus influenzae was performed in Mueller-Hinton broth supplemented with Fildes extract (Oxoid, Wesel, Federal Republic of Germany). To ensure sufficient growth, all beta-hemolytic streptococci were tested with Iso-Sensitest broth (Oxoid). All Staphylococcus aureus isolates were screened for penicillinase production with the chromogenic cephalosporin nitrocefin (Becton Dickinson Labware, Heidelberg, Federal Republic of Germany). Overnight cultures from all Staphylococcus aureus isolates were diluted 1:100 and grown further in Iso-Sensitest broth containing 25 p,g of 7-aminocephalosporanic acid per ml as the inducer. After a 4-h period of growth the bacteria were removed by centrifugation at 3,000 x g for 15 min, and the supernatant was screened for penicillinase production. A change from yellow to red within 30 min was considered positive. All antibiotics used in this study were kindly supplied by the manufacturers, including the new agent HRE 664, which was from Hoechst AG, Frankfurt, Federal Republic of Germany.
Although the penem HRE 664 was not as active as some of the other agents against members of the family Enterobacteriaceae, it was noteworthy that all the MICS for 90% of the strains tested were between 2 and 4 ,ug/ml (Table 1 ). In general HRE 664 displayed activity against the Enterobacteriaceae comparable to that of the penem compound Sch 34343, but it was somewhat less active (one or two dilution steps) than imipenem. Piperacillin was the least active agent included in this study. It should be mentioned that HRE 664 was active against ceftriaxone-, ceftazidime-, and aztreonam-resistant Enterobacter spp., Citrobacter freundii, and Serratia spp. isolates, as was the case for the compound Sch 34343 (Schering Corp., Bloomfield, N.J.) and imipenem (Table 1) . Moreover, it was active against the ceftriaxoneresistant Proteus spp. isolates.
The activity of HRE 664 against Acinetobacter spp. was rather marginal; it was 64-fold less active than imipenem and was not more active than the broad-spectrum cephalosporins (Table 1) . HRE 664 lacked activity against Pseudomonas aeruginosa, as was the case for Sch 34343.
The Haemophilus influenzae isolates, including four betalactamase-producing (TEM-1 enzyme) strains, were equally susceptible to both penems, but the broad-spectrum cephalosporins and aztreonam were somewhat more active.
All oxacillin-susceptible (penicillinase-producing) Staphylococcus aureus isolates were highly susceptible to HRE 664, which was eightfold more active than oxacillin.
On the other hand, HRE 664 was poorly active against oxacillin-resistant (no penicillinase production) Staphylococcus aureus isolates. All other beta-lactams were even less active ( comparable to that of the penem compound Sch 34343; however, imipenem was fourfold more active. Both penems were as active against Streptococcus faecalis as piperacillin and one or two dilution steps less active than imipenem (Table 1 ).
From the results described above, HRE 664 exhibits antibacterial activity that is comparable to those of other penems; however, it is not active against Pseudomonas aeruginosa, which appears to be the major difference between HRE 664 and CGP 31608 (CIBA-GEIGY). When compared with previously published data (7, 11) , HRE 664 is much more active against Haemophilus influenzae and grampositive rods.
With respect to oxacillin-resistant Staphylococcus aureus isolates, our findings do not entirely correspond to previously reported data (6, 9). As our findings suggest, there is a complete cross resistance between all beta-lactam compounds. At present, it cannot be determined which data are more relevant.
